Phreesia (NYSE:PHR) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Phreesia (NYSE:PHR) from a hold rating to a buy rating in a research note issued to investors on Saturday morning,Wall Street Zen reports.

PHR has been the subject of a number of other research reports. Robert W. Baird upped their target price on Phreesia from $10.00 to $11.00 and gave the stock a “neutral” rating in a report on Friday, September 4th. Citigroup reaffirmed a “market perform” rating on shares of Phreesia in a research report on Friday, September 4th. Weiss Ratings downgraded Phreesia from a “sell (d+)” rating to a “sell (d)” rating in a report on Friday, September 4th. Needham & Company LLC reissued a “buy” rating and issued a $14.00 price target on shares of Phreesia in a research report on Monday, August 31st. Finally, Raymond James Financial lowered Phreesia from an “outperform” rating to a “market perform” rating in a research report on Tuesday, September 8th. Eight investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $14.07.

Phreesia Price Performance

Shares of PHR opened at $10.85 on Friday. The company has a 50 day moving average price of $11.05 and a 200-day moving average price of $10.18. Phreesia has a fifty-two week low of $7.77 and a fifty-two week high of $24.07. The stock has a market capitalization of $673.71 million, a PE ratio of 63.85 and a beta of 0.84. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.76 and a current ratio of 1.76.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Wednesday, September 2nd. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.06). The business had revenue of $129.46 million for the quarter, compared to the consensus estimate of $129.06 million. Phreesia had a net margin of 2.06% and a return on equity of 5.22%. Phreesia’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.01 earnings per share. Equities analysts predict that Phreesia will post 0.33 earnings per share for the current fiscal year.

Insider Activity

In other news, General Counsel Allison C. Hoffman sold 6,662 shares of the company’s stock in a transaction on Monday, September 21st. The stock was sold at an average price of $10.08, for a total transaction of $67,152.96. Following the transaction, the general counsel directly owned 266,574 shares of the company’s stock, valued at approximately $2,687,065.92. This represents a 2.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 5.20% of the company’s stock.

Institutional Trading of Phreesia

A number of institutional investors have recently made changes to their positions in PHR. Rockefeller Capital Management L.P. raised its stake in shares of Phreesia by 354.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock valued at $47,000 after buying an additional 2,149 shares during the last quarter. Allworth Financial LP lifted its holdings in shares of Phreesia by 78.3% in the 2nd quarter. Allworth Financial LP now owns 5,613 shares of the company’s stock valued at $58,000 after buying an additional 2,465 shares during the period. Diversified Trust Co boosted its stake in shares of Phreesia by 5.8% in the first quarter. Diversified Trust Co now owns 54,418 shares of the company’s stock worth $456,000 after buying an additional 2,996 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in shares of Phreesia by 1,119.8% in the first quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock worth $27,000 after buying an additional 3,001 shares during the last quarter. Finally, Integrated Wealth Concepts LLC boosted its stake in shares of Phreesia by 37.2% in the second quarter. Integrated Wealth Concepts LLC now owns 14,129 shares of the company’s stock worth $145,000 after buying an additional 3,834 shares during the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc is a healthcare technology company that provides software and services designed to simplify and automate the patient intake process. Its platform helps healthcare organizations manage registration, consent forms, clinical questionnaires, insurance and demographic information, payments, and other administrative tasks through digital tools.

The company’s offerings are used by medical practices, health systems, and other healthcare organizations to improve patient engagement and support administrative and revenue-cycle workflows.